DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09

Fifty 410 vs TrimRx (2026): prices, structure, verdict

On tirzepatide, only TrimRx has a rankable figure: $349 a month all-in; Fifty 410 publishes no maintenance-dose tirzepatide figure we could capture (advertised start: $133), so a like-for-like number does not exist.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, only TrimRx has a rankable figure: $299 a month all-in; Fifty 410 does not offer semaglutide.

Fifty 410

Tirzepatide all-in
from $133 · no maintenance figure
Semaglutide all-in
not offered
12-mo tirzepatide (best path)
Membership
none
Shipping
unknown
Commitment
unknown
Cancellation
not published
Pharmacy
not named
States
not published
Insurance
no
Evidence
source-verified · 2026-08-05

TrimRx

Tirzepatide all-in
$349/mo · flat
Semaglutide all-in
$299/mo · flat
12-mo tirzepatide (best path)
$4,188
Membership
none
Shipping
included
Commitment
none month-to-month
Cancellation
check terms before prepaying
Pharmacy
not named
States
not published
Insurance
no
Evidence
source-verified · 2026-08-05

The two records, condensed

Fifty 410: the record, condensed

On tirzepatide, Fifty 410 advertises from $133 — and publishes no maintenance-dose figure we could capture. A starter-only price cannot be annualized, cannot be ranked, and should be treated as the bottom of an unstated range: before enrolling on its strength, get the 10 mg price in writing, and if the program will not state it, price the program at its ceiling rather than its floor.

Operationally at Fifty 410: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Fifty 410 page · visit Fifty 410 ↗

TrimRx: the record, condensed

TrimRx’s tirzepatide program bills $349 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #11 of 17 verified programs, with the floor $134/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $100 a month. A year at this figure: $4,188 monthly-billed.

Start with the load-bearing figure: $299 a month, all-in, is what TrimRx charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #17 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at TrimRx: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the TrimRx page · visit TrimRx ↗

Everything besides the price

Coverage: Fifty 410 publishes “not published”; TrimRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: Fifty 410 — unknown; not published. TrimRx — none month-to-month; check terms before prepaying.

Evidence: Fifty 410 source-verified (captured 2026-08-05); TrimRx source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

Switching between Fifty 410 and TrimRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Fifty 410: not published; TrimRx: check terms before prepaying) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

Which one, for whom

Cheapest tirzepatide month-to-month: TrimRx ($349).

Cheapest 12-month path: TrimRx at $4,188 (monthly billing).

Cheapest semaglutide: TrimRx ($299).

Without a shared rankable price, the verdict rests entirely on the structural axes above — and on which of these two makes your remaining questions answerable in writing before money moves.

Verdicts are computed from the records above — recompute them from the dataset. Full profiles: Fifty 410 · TrimRx.

Frequently asked

Which is cheaper, Fifty 410 or TrimRx?

On tirzepatide, only TrimRx has a rankable figure: $349 a month all-in ; Fifty 410 publishes no maintenance-dose tirzepatide figure we could capture (advertised start: $133), so a like-for-like number does not exist. On semaglutide, only TrimRx has a rankable figure: $299 a month all-in ; Fifty 410 does not offer semaglutide.

Is there a membership fee at Fifty 410 or TrimRx?

Fifty 410: none. TrimRx: none.

Where do these numbers come from?

From each provider's own published pages, captured 2026-08-05 (Fifty 410) and 2026-08-05 (TrimRx), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.

Is Fifty 410 or TrimRx dose-flat?

Fifty 410: no flat structure verified — get the maintenance-dose price in writing. TrimRx: yes — flat across doses. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.

Can I check both Fifty 410 and TrimRx against their sources?

Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-05), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.

What states do Fifty 410 and TrimRx serve?

Fifty 410: not published. TrimRx: not published. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.

Is shipping included at Fifty 410 and TrimRx?

Fifty 410: unknown. TrimRx: included. Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.

Which is more transparent, Fifty 410 or TrimRx?

On the checkable axes: pharmacy named — Fifty 410 no, TrimRx no; state list — Fifty 410 published, TrimRx published; cancellation terms — Fifty 410 published, TrimRx published; evidence — source-verified vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.

Fifty 410 vs NexLifeFifty 410 vs Yucca HealthFifty 410 vs IVIM HealthFifty 410 vs ShedRxFifty 410 vs Mochi HealthFifty 410 vs FoundFifty 410 vs SkinnyRxFifty 410 vs Henry Meds